AnaptysBio Inc (ANAB)
31.87
-0.64
(-1.97%)
USD |
NASDAQ |
Sep 27, 16:00
31.86
-0.01
(-0.03%)
After-Hours: 20:00
AnaptysBio Accounts Receivable (Quarterly): 9.007M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 9.007M |
March 31, 2024 | 7.089M |
December 31, 2023 | 6.851M |
September 30, 2023 | 3.269M |
June 30, 2023 | 3.182M |
March 31, 2023 | 1.523M |
December 31, 2022 | 1.419M |
September 30, 2022 | 1.18M |
June 30, 2022 | 1.033M |
March 31, 2022 | 0.921M |
December 31, 2021 | 0.876M |
September 30, 2021 | 0.761M |
June 30, 2021 | 0.642M |
March 31, 2021 | 1.247M |
December 31, 2020 | 0.00 |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | 5.00M |
December 31, 2019 |
Date | Value |
---|---|
September 30, 2019 | |
June 30, 2019 | 5.00M |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | 5.00M |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 1.225M |
September 30, 2016 | 0.86M |
June 30, 2016 | 0.98M |
March 31, 2016 | 1.191M |
December 31, 2015 | 1.226M |
September 30, 2015 | 1.913M |
June 30, 2015 | 2.757M |
December 31, 2014 | 1.455M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
9.007M
Maximum
Jun 2024
2.75M
Average
1.333M
Median
Accounts Receivable (Quarterly) Benchmarks
Regeneron Pharmaceuticals Inc | 5.717B |
Ligand Pharmaceuticals Inc | 37.48M |
Agios Pharmaceuticals Inc | 3.762M |
ADMA Biologics Inc | 30.11M |
Black Diamond Therapeutics Inc | -- |